- India to maintain edge in generics - Business Standard
- 'India has an edge over Japan in generics' - Business Standard
- IFCR plans to enter healthcare sector - ISI - Emerging Markets
- 'China will snatch our market from us' - Business Standard
- UK keen on strong bonds with Indian drug controllers for quality - Business Standard
Japanese Pharma cos see big opportunities in India - ISI - Emerging Markets
Japanese Pharma cos see big opportunities in IndiaISI - Emerging MarketsMr Toda said India was strong in IT and attractive environment for clinical research, while its weakness lay in “bad reputation” on quality of medicines and ...India to maintain edge in genericsBusiness Standardall 2 news articles »
